Huglear Chewable Tablets 4 mg (Montelukast Sodium)
Montelukast Sodium 4.16mg
Tablet · Prescription medication
Hugons Co., Ltd.
MFDS item code 202000090 · Approved 2020.01.07
This product's status changed to Expired on 2025.01.07. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Prevention and treatment of asthma; relief of seasonal and perennial allergic rhinitis symptoms
This medication is used to prevent asthma attacks and for prolonged treatment. It is also effective in relieving the symptoms of seasonal and perennial allergic rhinitis. Therefore, it helps patients with asthma and allergic rhinitis in symptom relief and management.
This medicine should be taken once daily. Patients with asthma should take it in the evening, while the dosing time for patients with allergic rhinitis should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 film once daily in the evening. Adults and adolescents 15 years of age and older: Take 10 mg of montelukast orally once daily. Adults and adolescents 15 years of age and older: Place 10 mg of montelukast on the tongue and allow it to dissolve; take without water. Pour the contents of 1 sachet into a cup, add 10 mL of water, stir well, and take. Do not open the package until immediately before use. After opening, suspend in water and take the entire amount immediately (within 15 minutes). Do not leave this medicine suspended in water for an extended period. This 4 mg granule formulation may be taken directly by mouth or mixed with a small amount (approximately 5 mL) of soft food at room temperature or cooler, such as baby food, breast milk, or porridge. Do not open the package until immediately before use. After opening, immediately (within 15 minutes) mix it with baby food, breast milk, or food, or take the entire amount as is. Do not leave this medicine mixed with baby food, breast milk, or food for an extended period; discard any remainder. This formulation is not intended to be mixed with beverages other than baby food or breast milk, but a beverage may be consumed immediately after taking it. This medicine may be taken without regard to meals.
Children 6~14 years of age (5 mg chewable tablet): Take 5 mg of montelukast once daily by chewing. Take this medicine 1 hour before or 2 hours after a meal. Children 2~5 years of age (4 mg chewable tablet): Take 4 mg of montelukast once daily by chewing. Take this medicine 1 hour before or 2 hours after a meal. Children 6~14 years of age (5 mg orally disintegrating tablet): Place 5 mg of montelukast on the tongue and, once it disintegrates, take without water. Take this medicine 1 hour before or 2 hours after a meal. Children 2~5 years of age (4 mg orally disintegrating tablet): Place 4 mg of montelukast on the tongue and, once it disintegrates, take without water. Take this medicine 1 hour before or 2 hours after a meal. Children 6~14 years of age (5 mg orally disintegrating film): Place 5 mg of montelukast on the tongue and allow it to dissolve; take without water. Take this medicine 1 hour before or 2 hours after a meal. Children 2~5 years of age (4 mg orally disintegrating film): Place 4 mg of montelukast on the tongue and allow it to dissolve; take without water. Take this medicine 1 hour before or 2 hours after a meal. Children 6~14 years of age (5 mg dry syrup): Administer 5mg of montelukast orally once daily. Take this medicine 1 hour before or 2 hours after a meal. Asthma - Children 2~5 years of age (4 mg granules): Administer 4 mg of montelukast orally once daily. Asthma - Infants 12 months to under 2 years of age: Administer 4 mg of this medicine orally once daily in the evening. Asthma - Efficacy and safety for asthma have not been established in infants under 12 months of age. Allergic rhinitis - Children 2~5 years of age: Administer 4 mg of montelukast orally once daily. Seasonal allergic rhinitis - Efficacy and safety for seasonal allergic rhinitis have not been established in infants under 2 years of age. Perennial allergic rhinitis - Infants 6 months to under 2 years of age: Administer 4mg of this medicine orally once daily. Perennial allergic rhinitis - Efficacy and safety for perennial allergic rhinitis have not been established in infants under 6 months of age.
This medication contains the artificial sweetener aspartame and should not be administered to patients with phenylketonuria, a hereditary condition. Aspartame is broken down into phenylalanine in the body, so individuals who must restrict their phenylalanine intake should not take this medication. Additionally, this medication contains lactose and should not be administered to patients with lactose intolerance or related genetic issues. This medication is not intended for use during acute asthma attacks, so appropriate emergency medications should be prepared in case of sudden worsening of asthma. During treatment, inhaled corticosteroid preparations should not be suddenly discontinued or changed, but should be gradually adjusted in accordance with the physician's instructions. It is advisable not to use aspirin or non-steroidal anti-inflammatory drugs simultaneously while taking this medication. Rarely, symptoms of vasculitis such as eosinophilia may appear; should such symptoms occur, contact a physician. Neuropsychiatric symptoms may arise during treatment, such as anxiety, depression, hallucinations, etc.; report any such changes to healthcare personnel immediately. This medication can be used by a variety of age groups from children to the elderly, but safety and effectiveness have not been established in infants under 6 months of age. There are no specific antidotes for overdose, so general treatment should be administered according to symptoms, following a physician's instructions. This medication is sensitive to light, so it should only be opened immediately before use, and should be stored out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to moisture and light, so it should be stored in a place free from humidity and light. It is best kept at room temperature between 1 to 30 degrees Celsius, in a tightly sealed container to prevent contact with air.
Pink chewable tablet with a biconvex oval shape
28 tablets (7 tablets/PTP x 4), 30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Montelukast Sodium 4.16mg
Tablet · Prescription medication
Hugons Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.